Development and Validation of the AIDS Scale among the System of Quality of Life Instruments for Chronic Diseases
Researchers from Guangdong Medical University have published a study on the development and validation of a new scale to measure the quality of life (QoL) of AIDS patients. The study aimed to address the pressing need to improve the QoL of AIDS patients, which is often lower than that of patients with other chronic diseases. The new scale, named QLICD-HIV V2.0, was developed using a programmed modular approach with multiple nominal and focus group discussions, in-depth interviews, and quantitative statistical procedures.
Key Takeaways:
- The study aimed to develop a new scale to measure the QoL of AIDS patients, which is often lower than that of patients with other chronic diseases.
- The new scale, QLICD-HIV V2.0, was developed using a programmed modular approach with multiple nominal and focus group discussions, in-depth interviews, and quantitative statistical procedures.
- The scale has 43 items, resulting in a structure of 4 domains, subdivided into 12 facets, and has high reliability overall with Cronbach's a coefficient and test-retest reliability of 0.90 and 0.88, respectively.
- The scale showed high reliability for each domain, with Cronbach's a coefficient ranging from 0.74 to 0.85 and test-retest reliabilities ranging from 0.69 to 0.89.
- The study concluded that QLICD-HIV V2.0 is a reliable and valid scale that can be used to measure the QoL of AIDS patients with Chinese characteristics.
Statistics:
- The prevalence of AIDS has shown a high increase in recent years, making it a major public health problem of international concern.
- The QoL of AIDS patients is often lower than that of patients with other chronic diseases.
- The new scale, QLICD-HIV V2.0, consists of 43 items and has a structure of 4 domains, subdivided into 12 facets.
- The Cronbach's a coefficient and test-retest reliability of the total scale were 0.90 and 0.88, respectively.
- The Cronbach's a coefficient for each domain ranged from 0.74 to 0.85, and test-retest reliabilities ranged from 0.69 to 0.89.
Sources:
- Development and validation of the AIDS scale among the system of quality of life instruments for chronic diseases (QLICD-HIV V2.0). BMC Infectious Diseases, 2025,25(1):1-11. (BMC Infectious Diseases - http://bmcinfectdis.biomedcentral.com).
- NewsRx. Studies from Guangdong Medical University Add New Findings in the Area of HIV/AIDS [Development and validation of the AIDS scale among the system of quality of life instruments for chronic diseases (QLICD-HIV V2.0)]. AIDS Weekly. October 20, 2025; p 214.